Increased risk of hypoglycaemia w/ miconazole systemic/oromucosal gel, systemic phenylbutazone, alcohol. Potentiated blood glucose-lowering effect w/ other antidiabetic agents (insulins, acarbose, metformin, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, GLP-1 receptor agonist), β-blockers, fluconazole, ACE inhibitors (captopril, enalapril), H2
-receptor antagonists, MAOIs, sulphonamides, clarithromycin, NSAIDs. Diabetogenic effect of danazol. Increased blood glucose levels w/ chlorpromazine, glucocorticoids, ritodrine, salbutamol, terbutaline IV. Potentiated anticoagulation w/ warfarin. Decreased exposure by St. John's wort. Risk of dysglycaemia w/ fluoroquinolones.